E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway

被引:78
作者
Contreras-Paredes, Adriana [1 ]
De la Cruz-Hernandez, Erick [1 ]
Martinez-Ramirez, Imelda [1 ]
Duenas-Gonzalez, Alfonso [1 ]
Lizano, Marcela [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Biomed Res Inst IIBM, Natl Canc Inst INCan, Unit Biomed Res Canc, Mexico City 14080, DF, Mexico
关键词
HPV variants; hDlg; E6; Akt/PKB; MAPK; PI3K; TYPE-16; E6; HPV E6; GENETIC ALTERATIONS; CERVICAL NEOPLASIA; METHYLATION STATUS; PTEN; ACTIVATION; EXPRESSION; PHOSPHORYLATION; PROGRESSION;
D O I
10.1016/j.virol.2008.09.040
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Intra-type genome variations of high risk Human papillomavirus (HPV) have been associated with a differential threat for cervical cancer development. In this work, the effect of HPV18 E6 isolates in Akt/PKB and Mito.-en-associated protein kinase (MAPKs) signaling pathways and its implication in cell proliferation were analyzed. E6 from HPV types 16 and 18 are able to bind and promote degradation of Human disc large (hDlg). Our results show that E6 variants differentially modulate hDlg degradation, rebounding in levels of activated PTEN and PKB. HPV18 E6 variants are also able to upregulate phospho-PI3K protein, strongly correlating with activated MAPKs and cell proliferation. Data was supported by the effect of E6 silencing in HPV18-containing HeLa cells, as well as hDlg silencing in the tested cells. Results suggest that HPV18 intra-type variations may derive in differential abilities to activate cell-signaling pathways such as Akt/PKB and MAPKs, directly involved in cell survival and proliferation. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:78 / 85
页数:8
相关论文
共 62 条
  • [1] Adey NB, 2000, CANCER RES, V60, P35
  • [2] Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia:: Frequent PIK3CA amplification and AKT phosphorylation
    Bertelsen, BI
    Steine, SJ
    Sandvei, R
    Molven, A
    Laerum, OD
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (08) : 1877 - 1883
  • [3] The causal relation between human papillomavirus and cervical cancer
    Bosch, FX
    Lorincz, A
    Muñoz, N
    Meijer, CJLM
    Shah, KV
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) : 244 - 265
  • [4] Melanocortin-3 receptor activates MAP kinase via PI3 kinase
    Chai, Biaoxin
    Li, Ji-Yao
    Zhang, Weizhen
    Ammori, John B.
    Mulholland, Michael W.
    [J]. REGULATORY PEPTIDES, 2007, 139 (1-3) : 115 - 121
  • [5] Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras
    Chakrabarti, O
    Veeraraghavalu, K
    Tergaonkar, V
    Liu, Y
    Androphy, EJ
    Stanley, MA
    Krishna, S
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (11) : 5934 - 5945
  • [6] Epigenetic and genetic alternation of PTEN in cervical neoplasm
    Cheung, TH
    Lo, KWK
    Yim, SF
    Chan, LKY
    Heung, MS
    Chan, CS
    Cheung, AYK
    Chung, TKH
    Wong, YF
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 93 (03) : 621 - 627
  • [7] Persistence and load of high-risk hpv are predictors for development of high-grade cervical lesions:: A longitudinal French cohort study
    Dalstein, W
    Riethmuller, D
    Prétet, JL
    Carval, KL
    Sautière, JL
    Carbillet, JP
    Kantelip, B
    Schaal, JP
    Mougin, C
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (03) : 396 - 403
  • [8] Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences
    De la Cruz-Hernández, E
    García-Carrancá, A
    Mohar-Betancourt, A
    Dueñas-González, A
    Contreras-Paredes, A
    Pérez-Cardenas, E
    Herrera-Goepfert, R
    Lizano-Soberón, M
    [J]. JOURNAL OF GENERAL VIROLOGY, 2005, 86 : 2459 - 2468
  • [9] RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase -: art. no. e46
    Donzé, O
    Picard, D
    [J]. NUCLEIC ACIDS RESEARCH, 2002, 30 (10) : e46
  • [10] DONZE O, 2002, NUCL AC RES, V15, P30